Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

A restrictive use of oral glucocorticoids in systemic lupus erythematosus prevents damage without worsening long-term disease control: An observational study.

Ruiz-Arruza I, Lozano J, Cabezas-Rodriguez I, Medina JA, Ugarte A, Erdozain JG, Ruiz-Irastorza G.

Arthritis Care Res (Hoboken). 2017 Jul 13. doi: 10.1002/acr.23322. [Epub ahead of print]

PMID:
28704598
2.

Predictors of peripheral arterial disease in SLE change with patient's age.

Erdozain JG, Villar I, Nieto J, Ruiz-Arruza I, Ruiz-Irastorza G.

Lupus Sci Med. 2017 Jan 12;4(1):e000190. doi: 10.1136/lupus-2016-000190. eCollection 2017.

3.

New insights into the genetic component of non-infectious uveitis through an Immunochip strategy.

Márquez A, Cordero-Coma M, Martín-Villa JM, Gorroño-Echebarría MB, Blanco R, Díaz Valle D, Del Rio MJ, Blanco A, Olea JL, Cordero Y, Capella MJ, Díaz-Llopis M, Ortego-Centeno N, Ruiz-Arruza I, Llorenç V, Adán A, Fonollosa A, Ten Berge J, Atan D, Dick AD, De Boer JH, Kuiper J, Rothova A, Martín J.

J Med Genet. 2017 Jan;54(1):38-46. doi: 10.1136/jmedgenet-2016-104144. Epub 2016 Sep 8.

PMID:
27609017
4.

Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis.

Fonollosa A, Valsero S, Artaraz J, Ruiz-Arruza I.

J Ophthalmic Inflamm Infect. 2016 Dec;6(1):31. doi: 10.1186/s12348-016-0101-4. Epub 2016 Aug 30.

5.

Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study.

Amengual O, Forastiero R, Sugiura-Ogasawara M, Otomo K, Oku K, Favas C, Delgado Alves J, Žigon P, Ambrožič A, Tomšič M, Ruiz-Arruza I, Ruiz-Irastorza G, Bertolaccini ML, Norman GL, Shums Z, Arai J, Murashima A, Tebo AE, Gerosa M, Meroni PL, Rodriguez-Pintó I, Cervera R, Swadzba J, Musial J, Atsumi T.

Lupus. 2017 Mar;26(3):266-276. doi: 10.1177/0961203316660203. Epub 2016 Aug 20.

PMID:
27510605
6.

SAFETY AND EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO INFECTIOUS UVEITIS.

Fonollosa A, Llorenç V, Artaraz J, Jimenez B, Ruiz-Arruza I, Agirrebengoa K, Cordero-Coma M, Costales-Mier F, Adan A.

Retina. 2016 Sep;36(9):1778-85. doi: 10.1097/IAE.0000000000001001.

PMID:
27183031
7.

Study of association of CTLA4 gene variants to non-anterior uveitis.

Leon Rodriguez DA, Serrano Lopera A, Cordero-Coma M, Márquez A, Fonollosa A, Ruiz-Arruza I, Callejas JL, García Serrano JL, Díaz Valle D, Pato E, Cañal J, del Rio MJ, Capella MJ, Blanco A, Olea JL, Cordero Y, Martín-Villa JM, Gorroño-Echebarría MB, Molins B, Adán A, Martin J.

Tissue Antigens. 2015 Nov;86(5):373-6. doi: 10.1111/tan.12668. Epub 2015 Sep 16.

PMID:
26373706
8.

Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.

Ruiz-Arruza I, Barbosa C, Ugarte A, Ruiz-Irastorza G.

Autoimmun Rev. 2015 Oct;14(10):875-9. doi: 10.1016/j.autrev.2015.05.011. Epub 2015 Jun 1. Review.

PMID:
26044819
9.

Anterior tuberculous scleritis: A diagnostic challenge.

Vargas-Kelsh JG, Fonollosa A, Artaraz J, del Rio R, Silva-Ribeiro AR, Ruiz-Arruza I.

Arch Soc Esp Oftalmol. 2015 Dec;90(12):585-7. doi: 10.1016/j.oftal.2015.02.013. Epub 2015 Mar 25. English, Spanish.

PMID:
25817957
10.

Specific association of IL17A genetic variants with panuveitis.

Mucientes A, Márquez A, Cordero-Coma M, Martín-Villa JM, Gorroño-Echebarría MB, Blanco R, Díaz Valle D, Benítez-del-Castillo JM, del Rio MJ, Blanco A, Olea JL, Cordero Y, Capella MJ, Gonzalez J, Díaz-Llopis M, Ortego-Centeno N, Adán A, Ruiz-Arruza I, Llorenç V, Fonollosa A, Martín J.

Br J Ophthalmol. 2015 Apr;99(4):566-70. doi: 10.1136/bjophthalmol-2014-306106. Epub 2015 Jan 16.

PMID:
25595174
11.

Minimal disease activity and anti-tumor necrosis factor therapy in psoriatic arthritis.

Haddad A, Thavaneswaran A, Ruiz-Arruza I, Pellett F, Chandran V, Cook RJ, Gladman DD.

Arthritis Care Res (Hoboken). 2015 May;67(6):842-7. doi: 10.1002/acr.22529.

12.

Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.

Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G.

Rheumatology (Oxford). 2014 Aug;53(8):1470-6. doi: 10.1093/rheumatology/keu148. Epub 2014 Mar 27.

PMID:
24681836
13.

[Vascular risk in outpatient from Internal Medicine departments. MICARE Study].

de la Peña A, Roca-Cusachs A, Suárez C, Bonet S; en nombre del grupo MICARE.

Med Clin (Barc). 2013 Mar 16;140(6):246-54. doi: 10.1016/j.medcli.2012.05.043. Epub 2012 Nov 28. Spanish.

PMID:
23199827
14.

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies.

Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R, Erkan D, Krilis S, Machin S, Pengo V, Pierangeli S, Tektonidou M, Khamashta M.

Lupus. 2011 Feb;20(2):206-18. doi: 10.1177/0961203310395803.

PMID:
21303837
15.

Predictors of major infections in systemic lupus erythematosus.

Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C.

Arthritis Res Ther. 2009;11(4):R109. doi: 10.1186/ar2764. Epub 2009 Jul 15.

Supplemental Content

Loading ...
Support Center